Pharmaceuticals, Biotechnology and Life Sciences
– Trial did not achieve statistically significant improvements in abdominal pain relative to placebo – – Companies plan to discontinue…
WOBURN, Mass.–(BUSINESS WIRE)–Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair…
James Hindman, a veteran global and strategic senior financial executive, brings extensive experience in the pharmaceutical, biologics and medical device…
New company brand identity and Chief Scientific Officer appointment reflect long-term focus on developing small molecule therapeutics that regulate conformation…
NEW YORK–(BUSINESS WIRE)–$TYME—Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will…
ISTURISA® (osilodrostat) Is Now Exclusively Available Through AnovoRx Specialty Pharmacy. In an Effort to Increase Patient Access to ISTURISA, Recordati…
ISTURISA® (osilodrostat) Is Now Exclusively Available Through AnovoRx Specialty Pharmacy. In an Effort to Increase Patient Access to ISTURISA, Recordati…
DUBLIN–(BUSINESS WIRE)–The “2020 COVID-19 Clinical Trials Guide – Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025” report has…
– Arcus to Receive $175 Million Upfront Payment and $200 Million Equity Investment and up to $1.6 Billion Plus in…
Clinical Data Offer Meaningful Diagnostic Information for Patients in the Lung Cancer Continuum of Care BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc., a…